Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duggan

Showing results (1201-1210 of 4,005) with videos related to

Pageof 401
Sort By:
Journal of Clinical Pharmacology|August 3, 2004
Lack of attenuation in the antitumor effect of tamoxifen by chronic CYP isoform inhibitionDavid Lehmann, Jamie Nelsen, Vijay Ramanath, et al.
Irish Veterinary Journal|August 3, 2018
Evaluation of a coaching workshop for the management of veterinary nursing students' OSCE-associated test anxietyKaren Dunne, Jenny Moffett, Sinead T Loughran, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|July 25, 2018
OBTAIN E: outcome benefits of tranexamic acid in hip arthroplasty with enoxaparin: a randomised double-blinded controlled trialAndrew Fraval, Sam Duncan, Theresa Murray, et al.
Brain Research|October 7, 1985
A differential effect of naloxone on transmission of impulses in primary afferents to ventral roots and ascending spinal tractsA W Duggan, J G Hall, F W Foong, et al.
The Medical Journal of Australia|May 5, 2010
Australian clinical practice guidelines--a national studyHeather A Buchan, Kay C Currie, Emma J Lourey, et al.
Drugs & Aging|April 3, 2012
Bazedoxifene: a guide to its use in postmenopausal osteoporosisGillian M Keating, Katherine A Lyseng-Williamson, Sean T Duggan, et al.
Journal of the Neurological Sciences|September 1, 1996
alpha-Sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutationsD J Duggan, M Fanin, E Pegoraro, et al.
Journal of Affective Disorders|November 5, 2013
A comparison of vulnerability factors in patients with persistent and remitting lifetime symptom course of depressionThorsten Barnhofer, Kate Brennan, Catherine Crane, et al.
Molecular and Cellular Biochemistry|May 18, 2022
Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesisWilliam P Duggan, Emer O'Connell, Jochen H M Prehn, et al.
Journal of Medical Internet Research|July 31, 2020
A Mobile Health Approach for Improving Outcomes in Suicide Prevention (SafePlan)Conor O'Grady, Ruth Melia, John Bogue, et al.
Pageof 401

Showing results (1201-1210 of 4,005) with videos related to

Sort By:
Pageof 401
Journal of Clinical Pharmacology|August 3, 2004
Lack of attenuation in the antitumor effect of tamoxifen by chronic CYP isoform inhibitionDavid Lehmann, Jamie Nelsen, Vijay Ramanath, et al.
Irish Veterinary Journal|August 3, 2018
Evaluation of a coaching workshop for the management of veterinary nursing students' OSCE-associated test anxietyKaren Dunne, Jenny Moffett, Sinead T Loughran, et al.
Hip International : the Journal of Clinical and Experimental Research on Hip Pathology and Therapy|July 25, 2018
OBTAIN E: outcome benefits of tranexamic acid in hip arthroplasty with enoxaparin: a randomised double-blinded controlled trialAndrew Fraval, Sam Duncan, Theresa Murray, et al.
Brain Research|October 7, 1985
A differential effect of naloxone on transmission of impulses in primary afferents to ventral roots and ascending spinal tractsA W Duggan, J G Hall, F W Foong, et al.
The Medical Journal of Australia|May 5, 2010
Australian clinical practice guidelines--a national studyHeather A Buchan, Kay C Currie, Emma J Lourey, et al.
Drugs & Aging|April 3, 2012
Bazedoxifene: a guide to its use in postmenopausal osteoporosisGillian M Keating, Katherine A Lyseng-Williamson, Sean T Duggan, et al.
Journal of the Neurological Sciences|September 1, 1996
alpha-Sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutationsD J Duggan, M Fanin, E Pegoraro, et al.
Journal of Affective Disorders|November 5, 2013
A comparison of vulnerability factors in patients with persistent and remitting lifetime symptom course of depressionThorsten Barnhofer, Kate Brennan, Catherine Crane, et al.
Molecular and Cellular Biochemistry|May 18, 2022
Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesisWilliam P Duggan, Emer O'Connell, Jochen H M Prehn, et al.
Journal of Medical Internet Research|July 31, 2020
A Mobile Health Approach for Improving Outcomes in Suicide Prevention (SafePlan)Conor O'Grady, Ruth Melia, John Bogue, et al.
Pageof 401